Isolation and characterization of gallium resistant Pseudomonas aeruginosa mutants

Adhikari, 1995, Biochemical characterization of a Haemophilus influenzae periplasmic iron transport operon, J. Biol. Chem., 270, 25142, 10.1074/jbc.270.42.25142 Anraku, 1988, Bacterial electron transport chains, Annu. Rev. Biochem., 57, 101, 10.1146/annurev.bi.57.070188.000533 Banin, 2008, The potential of desferrioxamine-gallium as an anti-Pseudomonas therapeutic agent, Proc. Natl. Acad. Sci. U.S.A., 105, 16761, 10.1073/pnas.0808608105 Bjarnsholt, 2010, Interference of Pseudomonas aeruginosa signalling and biofilm formation for infection control, Expert Rev. Mol. Med., 12, e11, 10.1017/S1462399410001420 Bjarnsholt, 2011, Interference of Pseudomonas aeruginosa signalling and biofilm formation for infection control, Expert Rev. Mol. Med., 12, e11, 10.1017/S1462399410001420 Cox, 1986, Role of pyocyanin in the acquisition of iron from transferrin, Infect Immun., 52, 263, 10.1128/IAI.52.1.263-270.1986 Chakrabarty, 1975, Transformation of Pseudomonas putida and Escherichia coli with plasmid-linked drug-resistance factor DNA, Proc. Natl. Acad. Sci. U.S.A., 72, 3647, 10.1073/pnas.72.9.3647 Chitambar, 1991, Targeting iron-dependent DNA synthesis with gallium and transferrin-gallium, Pathobiology, 59, 3, 10.1159/000163609 de Lorenzo, 1990, Mini-Tn5 transposon derivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in gram-negative eubacteria, J. Bacteriol., 172, 6568, 10.1128/jb.172.11.6568-6572.1990 Essar, 1990, Identification and characterization of genes for a second anthranilate synthase in Pseudomonas aeruginosa: interchangeability of the two anthranilate synthases and evolutionary implications, J. Bacteriol., 172, 884, 10.1128/jb.172.2.884-900.1990 Fontecave, 1990, Reduction of the Fe(III)-tyrosyl radical center of Escherichia coli ribonucleotide reductase by dithiothreitol, J. Biol. Chem., 265, 10919, 10.1016/S0021-9258(19)38534-5 Frederick, 2001, Factors affecting catalase expression in Pseudomonas aeruginosa biofilms and planktonic cells, Appl. Environ. Microbiol., 67, 1375, 10.1128/AEM.67.3.1375-1379.2001 Greenwald, 2008, The metal dependence of pyoverdine interactions with its outer membrane receptor FpvA, J. Bacteriol., 190, 6548, 10.1128/JB.00784-08 Hassett, 1993, Cloning and characterization of the Pseudomonas aeruginosa sodA and sodB genes encoding manganese- and iron-cofactored superoxide dismutase: demonstration of increased manganese superoxide dismutase activity in alginate-producing bacteria, J. Bacteriol., 175, 7658, 10.1128/jb.175.23.7658-7665.1993 Hidron, 2008, NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007, Infect. Control Hosp. Epidemiol., 29, 996, 10.1086/591861 Jones, 2009, Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997–2007), Diagn. Microbiol. Infect. Dis., 65, 331, 10.1016/j.diagmicrobio.2009.06.022 Kaneko, 2007, The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity, J. Clin. Invest., 117, 877, 10.1172/JCI30783 Kerr, 2009, Pseudomonas aeruginosa: a formidable and ever-present adversary, J. Hosp. Infect., 73, 338, 10.1016/j.jhin.2009.04.020 Lambert, 2011, Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study, Lancet Infect. Dis., 11, 30, 10.1016/S1473-3099(10)70258-9 Lambert, 2002, Mechanisms of antibiotic resistance in Pseudomonas aeruginosa, J. R. Soc. Med., 95, 22L 6 Lesic, 2007, Inhibitors of pathogen intercellular signals as selective anti-infective compounds, PLoS Pathog., 3, 1229, 10.1371/journal.ppat.0030126 Liberati, 2006, An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants, Proc. Natl. Acad. Sci. U.S.A., 103, 2833, 10.1073/pnas.0511100103 Logan, 1981, Comparative pharmacokinetics of 67Ga and 59Fe in humans, Int. J. Nucl. Med. Biol., 8, 271, 10.1016/0047-0740(81)90033-4 Macé, 2008, Identification of biofilm-associated cluster (bac) in Pseudomonas aeruginosa involved in biofilm formation and virulence, PLoS ONE, 3, e3897, 10.1371/journal.pone.0003897 Maeda, 2011, Quorum quenching quandary: resistance to antivirulence compounds?, ISME J., 6, 493, 10.1038/ismej.2011.122 Mahar, 2010, Pseudomonas aeruginosa bacteraemia in burns patients: risk factors and outcomes, Burns, 36, 1228, 10.1016/j.burns.2010.05.009 Marlovits, 2002, The membrane protein FeoB contains an intramolecular G protein essential for Fe(II) uptake in bacteria, Proc. Natl. Acad. Sci. U.S.A., 99, 16243, 10.1073/pnas.242338299 McDermott, 2012, Effects of Pseudomonas aeruginosa virulence factor pyocyanin on human urothelial cell function and viability, J. Urol., 187, 1087, 10.1016/j.juro.2011.10.129 Mutlu, 2006, Severe pseudomonal infections, Curr. Opin. Crit. Care, 12, 458, 10.1097/01.ccx.0000244127.92612.b4 O’Malley, 2004, Pseudomonas aeruginosa pyocyanin directly oxidizes glutathione and decreases its levels in airway epithelial cells, Am. J. Physiol. Lung Cell Mol. Physiol., 287, L94, 10.1152/ajplung.00025.2004 O’Toole, 1999, Genetic approaches to study of biofilms, Methods Enzymol., 310, 91, 10.1016/S0076-6879(99)10008-9 Page, 2009, Prospects for the next anti-Pseudomonas drug, Curr. Opin. Pharmacol., 9, 558, 10.1016/j.coph.2009.08.006 Paterson, 2006, The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species, Clin. Infect. Dis., 43, S43L 8 Poole, 2002, Outer membranes and efflux: the path to multidrug resistance in Gram-negative bacteria, Curr. Pharm. Biotechnol., 3, 77, 10.2174/1389201023378454 Poole, 2011, Pseudomonas aeruginosa: resistance to the max, Front. Microbiol., 2, 65, 10.3389/fmicb.2011.00065 Ramos-González, 1998, Cloning, sequencing, and phenotypic characterization of the rpoS gene from Pseudomonas putida KT2440, J. Bacteriol., 180, 3421, 10.1128/JB.180.13.3421-3431.1998 Rasko, 2010, Anti-virulence strategies to combat bacteria-mediated disease, Nat. Rev. Drug Discov., 9, 117, 10.1038/nrd3013 Ren, 2005, Quorum-sensing antagonist (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone influences siderophore biosynthesis in Pseudomonas putida and Pseudomonas aeruginosa, Appl. Microbiol. Biotechnol., 66, 689, 10.1007/s00253-004-1691-6 Rzhepishevska, 2011, The antibacterial activity of Ga3+ is influenced by ligand complexation as well as the bacterial carbon source, Antimicrob. Agents Chemother., 55, 5568, 10.1128/AAC.00386-11 Sepandj, 2004, Minimum inhibitory concentration (MIC) versus minimum biofilm eliminating concentration (MBEC) in evaluation of antibiotic sensitivity of gram-negative bacilli causing peritonitis, Perit. Dial. Int., 24, 65, 10.1177/089686080402400107 Ueda, 2009, Connecting quorum sensing, c-di-GMP, pel polysaccharide, and biofilm formation in Pseudomonas aeruginosa through tyrosine phosphatase TpbA (PA3885), PLoS Pathog., 5, e1000483, 10.1371/journal.ppat.1000483 Veesenmeyer, 2009, Pseudomonas aeruginosa virulence and therapy: evolving translational strategies, Crit. Care Med., 37, 1777, 10.1097/CCM.0b013e31819ff137 Wandersman, 2004, Bacterial iron sources: from siderophores to hemophores, Annu. Rev. Microbiol., 58, 611, 10.1146/annurev.micro.58.030603.123811 Wang, 2011, Phenazine-1-carboxylic acid promotes bacterial biofilm development via ferrous iron acquisition, J. Bacteriol., 193, 3606, 10.1128/JB.00396-11 West, 1994, Construction of improved Escherichia–Pseudomonas shuttle vectors derived from pUC18/19 and sequence of the region required for their replication in Pseudomonas aeruginosa, Gene, 148, 81, 10.1016/0378-1119(94)90237-2 Wright, 2009, A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy, Clin. Otolaryngol., 34, 349, 10.1111/j.1749-4486.2009.01973.x Yeats, 2004, The PepSY domain: a regulator of peptidase activity in the microbial environment?, Trends Biochem. Sci., 29, 169, 10.1016/j.tibs.2004.02.004 Zhanel, 2010, Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008), Antimicrob. Agents Chemother., 54, 4684, 10.1128/AAC.00469-10